Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Blueprint Medicines Corporation (BPMC) stock price today?
As of Jul 18, 2025, 8:00 PM UTC, Blueprint Medicines Corporation (BPMC) stock is trading at $129.46. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date BPMC stock quotes for informed trading decisions.
What is Blueprint Medicines Corporation's market capitalization?
Blueprint Medicines Corporation (BPMC) has a market capitalization of approximately $8.4B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Blueprint Medicines Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the BPMC stock price changes.
What is the 52-week range for Blueprint Medicines Corporation stock?
Blueprint Medicines Corporation (BPMC) stock has traded in a 52-week range of $73.04 — $129.55. The 52-week range shows the highest and lowest prices at which BPMC traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Blueprint Medicines Corporation stock price to this range provides context for recent price action.
How much trading volume does Blueprint Medicines Corporation stock have?
Blueprint Medicines Corporation (BPMC) stock recently traded approximately 3M shares. Trading volume indicates market liquidity and investor interest in BPMC. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Blueprint Medicines Corporation stock.
Does Blueprint Medicines Corporation pay dividends to shareholders?
Yes, Blueprint Medicines Corporation (BPMC) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Blueprint Medicines Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Blueprint Medicines Corporation's intraday price range?
Today, Blueprint Medicines Corporation (BPMC) stock has traded in a range of $129.46 — $129.46. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring BPMC's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Blueprint Medicines Corporation stock data?
AlphaPilot sources real-time BPMC stock quotes, fundamental financial data, and historical price charts for Blueprint Medicines Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Blueprint Medicines Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of BPMC stock performance.